

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.16912709 |
| 2 | vocalization behavior (GO:0071625) | 3.97843861 |
| 3 | synaptic vesicle maturation (GO:0016188) | 3.89252868 |
| 4 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.86961034 |
| 5 | locomotory exploration behavior (GO:0035641) | 3.63960417 |
| 6 | synaptic vesicle exocytosis (GO:0016079) | 3.60433750 |
| 7 | layer formation in cerebral cortex (GO:0021819) | 3.55765043 |
| 8 | glutamate secretion (GO:0014047) | 3.50861696 |
| 9 | neuron cell-cell adhesion (GO:0007158) | 3.50797518 |
| 10 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.49799655 |
| 11 | cerebellar granule cell differentiation (GO:0021707) | 3.49363699 |
| 12 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.47086456 |
| 13 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.44251828 |
| 14 | proline transport (GO:0015824) | 3.43949655 |
| 15 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.41355487 |
| 16 | activation of protein kinase A activity (GO:0034199) | 3.33139612 |
| 17 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.32898938 |
| 18 | protein localization to synapse (GO:0035418) | 3.32248445 |
| 19 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.29982929 |
| 20 | neuronal ion channel clustering (GO:0045161) | 3.29858067 |
| 21 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.28690142 |
| 22 | cell communication by electrical coupling (GO:0010644) | 3.27728717 |
| 23 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.22789038 |
| 24 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.22180438 |
| 25 | neurotransmitter secretion (GO:0007269) | 3.22155425 |
| 26 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.21563330 |
| 27 | regulation of ARF protein signal transduction (GO:0032012) | 3.21368035 |
| 28 | exploration behavior (GO:0035640) | 3.21107222 |
| 29 | neuron recognition (GO:0008038) | 3.18570547 |
| 30 | regulation of synapse structural plasticity (GO:0051823) | 3.17048303 |
| 31 | amino acid import (GO:0043090) | 3.15289578 |
| 32 | L-amino acid import (GO:0043092) | 3.12665539 |
| 33 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.08979264 |
| 34 | neuronal action potential propagation (GO:0019227) | 3.08491831 |
| 35 | cerebellar Purkinje cell layer development (GO:0021680) | 3.07132505 |
| 36 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.06467028 |
| 37 | cellular potassium ion homeostasis (GO:0030007) | 3.06067972 |
| 38 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.05080408 |
| 39 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.04605184 |
| 40 | axonal fasciculation (GO:0007413) | 3.02237780 |
| 41 | positive regulation of dendritic spine development (GO:0060999) | 3.01211749 |
| 42 | regulation of synaptic plasticity (GO:0048167) | 3.00783676 |
| 43 | regulation of synaptic vesicle transport (GO:1902803) | 3.00443919 |
| 44 | sodium ion export (GO:0071436) | 2.97261873 |
| 45 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.96147096 |
| 46 | cell communication involved in cardiac conduction (GO:0086065) | 2.92412436 |
| 47 | regulation of synapse maturation (GO:0090128) | 2.91661031 |
| 48 | gamma-aminobutyric acid transport (GO:0015812) | 2.88587981 |
| 49 | dendrite morphogenesis (GO:0048813) | 2.86875610 |
| 50 | positive regulation of neurotransmitter transport (GO:0051590) | 2.86709330 |
| 51 | regulation of neurotransmitter secretion (GO:0046928) | 2.84087531 |
| 52 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.81372332 |
| 53 | dendritic spine morphogenesis (GO:0060997) | 2.79210720 |
| 54 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.79011313 |
| 55 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.78973240 |
| 56 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.78666053 |
| 57 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.78615782 |
| 58 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.78173116 |
| 59 | positive regulation of membrane potential (GO:0045838) | 2.75733550 |
| 60 | membrane depolarization during action potential (GO:0086010) | 2.75317691 |
| 61 | dendritic spine organization (GO:0097061) | 2.74301773 |
| 62 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.71502383 |
| 63 | plasma membrane repair (GO:0001778) | 2.70347974 |
| 64 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.69350495 |
| 65 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.66205888 |
| 66 | regulation of membrane repolarization (GO:0060306) | 2.65240182 |
| 67 | cell migration in hindbrain (GO:0021535) | 2.64758915 |
| 68 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.64606211 |
| 69 | regulation of dendritic spine development (GO:0060998) | 2.63647348 |
| 70 | cellular sodium ion homeostasis (GO:0006883) | 2.61718147 |
| 71 | regulation of neurotransmitter transport (GO:0051588) | 2.61696156 |
| 72 | neurotransmitter transport (GO:0006836) | 2.60525244 |
| 73 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.60221821 |
| 74 | regulation of cell communication by electrical coupling (GO:0010649) | 2.60031470 |
| 75 | glutamate receptor signaling pathway (GO:0007215) | 2.59778518 |
| 76 | alanine transport (GO:0032328) | 2.57612182 |
| 77 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.56404865 |
| 78 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.55464292 |
| 79 | glycine transport (GO:0015816) | 2.55319511 |
| 80 | mating behavior (GO:0007617) | 2.54913045 |
| 81 | innervation (GO:0060384) | 2.52349780 |
| 82 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.52181233 |
| 83 | synapse assembly (GO:0007416) | 2.51799315 |
| 84 | axon extension (GO:0048675) | 2.51238665 |
| 85 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.50440937 |
| 86 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.50413975 |
| 87 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.50413975 |
| 88 | neuron-neuron synaptic transmission (GO:0007270) | 2.49826264 |
| 89 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.49169206 |
| 90 | vesicle transport along microtubule (GO:0047496) | 2.48988511 |
| 91 | synaptic transmission, glutamatergic (GO:0035249) | 2.48965099 |
| 92 | organelle transport along microtubule (GO:0072384) | 2.48388874 |
| 93 | cellular response to catecholamine stimulus (GO:0071870) | 2.47565961 |
| 94 | cellular response to monoamine stimulus (GO:0071868) | 2.47565961 |
| 95 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.46622651 |
| 96 | positive regulation of potassium ion transport (GO:0043268) | 2.45879534 |
| 97 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.45717426 |
| 98 | synapse organization (GO:0050808) | 2.44638230 |
| 99 | potassium ion import (GO:0010107) | 2.44354404 |
| 100 | postsynaptic membrane organization (GO:0001941) | 2.44296003 |
| 101 | potassium ion homeostasis (GO:0055075) | 2.42728344 |
| 102 | regulation of neurotransmitter levels (GO:0001505) | 2.42547014 |
| 103 | protein localization to endosome (GO:0036010) | 2.42151440 |
| 104 | central nervous system myelination (GO:0022010) | 2.42126320 |
| 105 | axon ensheathment in central nervous system (GO:0032291) | 2.42126320 |
| 106 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.41694732 |
| 107 | regulation of vesicle fusion (GO:0031338) | 2.41141244 |
| 108 | acidic amino acid transport (GO:0015800) | 2.41044713 |
| 109 | long-term memory (GO:0007616) | 2.40349884 |
| 110 | nucleobase catabolic process (GO:0046113) | 2.40146217 |
| 111 | neuromuscular process controlling posture (GO:0050884) | 2.38992271 |
| 112 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.38706072 |
| 113 | response to gravity (GO:0009629) | 2.38262978 |
| 114 | establishment of nucleus localization (GO:0040023) | 2.37187382 |
| 115 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.36945339 |
| 116 | detection of calcium ion (GO:0005513) | 2.36513327 |
| 117 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.35943763 |
| 118 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.35193834 |
| 119 | regulation of synaptic transmission (GO:0050804) | 2.35021672 |
| 120 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.34783205 |
| 121 | neuromuscular process controlling balance (GO:0050885) | 2.34157921 |
| 122 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.34055589 |
| 123 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.32923465 |
| 124 | transmission of nerve impulse (GO:0019226) | 2.32795874 |
| 125 | positive regulation of synapse maturation (GO:0090129) | 2.32763195 |
| 126 | chondroitin sulfate catabolic process (GO:0030207) | 2.32638112 |
| 127 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.32195602 |
| 128 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.32118431 |
| 129 | vesicle docking involved in exocytosis (GO:0006904) | 2.32099388 |
| 130 | regulation of postsynaptic membrane potential (GO:0060078) | 2.31771585 |
| 131 | positive regulation of dendrite development (GO:1900006) | 2.31421854 |
| 132 | axon cargo transport (GO:0008088) | 2.30655824 |
| 133 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.29134443 |
| 134 | synaptic vesicle endocytosis (GO:0048488) | 2.28755486 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.31777889 |
| 2 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.03255169 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.88470784 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.86974249 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.78753694 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.60577365 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.57316906 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.57316906 |
| 9 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.39280538 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.38617905 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.37320952 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.36080525 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.35171032 |
| 14 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.28069351 |
| 15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.27675519 |
| 16 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.23187144 |
| 17 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.05069765 |
| 18 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.01618763 |
| 19 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.01547864 |
| 20 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.00110740 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.97114260 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.93601825 |
| 23 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.92721436 |
| 24 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.90360457 |
| 25 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.86667676 |
| 26 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.81386689 |
| 27 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.74658297 |
| 28 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.65618827 |
| 29 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.62652534 |
| 30 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.62201100 |
| 31 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.60731620 |
| 32 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.57469309 |
| 33 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.54603810 |
| 34 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.52195638 |
| 35 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.51118598 |
| 36 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.47126156 |
| 37 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.45783410 |
| 38 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.45623931 |
| 39 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.43688956 |
| 40 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.42709371 |
| 41 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.42594747 |
| 42 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.42261576 |
| 43 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.41494575 |
| 44 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.36141834 |
| 45 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.35735645 |
| 46 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.34931017 |
| 47 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.33871099 |
| 48 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.32177749 |
| 49 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.30119338 |
| 50 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.28962036 |
| 51 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28720249 |
| 52 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.28526114 |
| 53 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.28433386 |
| 54 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.28341401 |
| 55 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.27310210 |
| 56 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.26952480 |
| 57 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.25967087 |
| 58 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.25094277 |
| 59 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.23509945 |
| 60 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.23071496 |
| 61 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.22233963 |
| 62 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.21683763 |
| 63 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.21614724 |
| 64 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.21268990 |
| 65 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.19973059 |
| 66 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.19452160 |
| 67 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.19301520 |
| 68 | P300_19829295_ChIP-Seq_ESCs_Human | 1.18226855 |
| 69 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17768942 |
| 70 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.17632416 |
| 71 | AR_25329375_ChIP-Seq_VCAP_Human | 1.17627668 |
| 72 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.15928979 |
| 73 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.15841448 |
| 74 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.14905557 |
| 75 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.14384642 |
| 76 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.14384642 |
| 77 | AR_19668381_ChIP-Seq_PC3_Human | 1.11955271 |
| 78 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.11845754 |
| 79 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.11804555 |
| 80 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.10463137 |
| 81 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.09229766 |
| 82 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.09035179 |
| 83 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.08048383 |
| 84 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.07292048 |
| 85 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.07111828 |
| 86 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.06702507 |
| 87 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.06612387 |
| 88 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.06360927 |
| 89 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.05066672 |
| 90 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.04170168 |
| 91 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.04074809 |
| 92 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03571923 |
| 93 | STAT3_23295773_ChIP-Seq_U87_Human | 1.03484284 |
| 94 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.03236597 |
| 95 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.03182309 |
| 96 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.02676189 |
| 97 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.02236916 |
| 98 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.02065209 |
| 99 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.01743586 |
| 100 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.01743586 |
| 101 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01132253 |
| 102 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.00996148 |
| 103 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.00921496 |
| 104 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.00033735 |
| 105 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.99883580 |
| 106 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99839029 |
| 107 | KDM2B_26808549_Chip-Seq_K562_Human | 0.99544188 |
| 108 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99516240 |
| 109 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.99050936 |
| 110 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.95551574 |
| 111 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.95473766 |
| 112 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.94477460 |
| 113 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.93380837 |
| 114 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.92680585 |
| 115 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.91832082 |
| 116 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.91709878 |
| 117 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.91638656 |
| 118 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.90846964 |
| 119 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.90042020 |
| 120 | RXR_22108803_ChIP-Seq_LS180_Human | 0.89999951 |
| 121 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.89709207 |
| 122 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.89643134 |
| 123 | TP53_16413492_ChIP-PET_HCT116_Human | 0.89549972 |
| 124 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.89449870 |
| 125 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.89003597 |
| 126 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.88748954 |
| 127 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88464257 |
| 128 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.87457341 |
| 129 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86929007 |
| 130 | TCF4_23295773_ChIP-Seq_U87_Human | 0.86911649 |
| 131 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.86871131 |
| 132 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.86487467 |
| 133 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86381862 |
| 134 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84308301 |
| 135 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.84135132 |
| 136 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.83965215 |
| 137 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.82415131 |
| 138 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.82397592 |
| 139 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.81976895 |
| 140 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.81469574 |
| 141 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.80117392 |
| 142 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.78170665 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.32097414 |
| 2 | MP0003880_abnormal_central_pattern | 3.33163469 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 2.99423028 |
| 4 | MP0004270_analgesia | 2.91764042 |
| 5 | MP0002837_dystrophic_cardiac_calcinosis | 2.87073597 |
| 6 | MP0000751_myopathy | 2.81049739 |
| 7 | MP0001968_abnormal_touch/_nociception | 2.41623266 |
| 8 | MP0009745_abnormal_behavioral_response | 2.37723462 |
| 9 | MP0002063_abnormal_learning/memory/cond | 2.37293786 |
| 10 | MP0002064_seizures | 2.23019210 |
| 11 | MP0009046_muscle_twitch | 2.21007052 |
| 12 | MP0006276_abnormal_autonomic_nervous | 2.19925214 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.19088177 |
| 14 | MP0009780_abnormal_chondrocyte_physiolo | 2.12919271 |
| 15 | MP0004858_abnormal_nervous_system | 2.10388744 |
| 16 | MP0002572_abnormal_emotion/affect_behav | 1.98378815 |
| 17 | MP0002735_abnormal_chemical_nociception | 1.96078801 |
| 18 | MP0002272_abnormal_nervous_system | 1.93884338 |
| 19 | MP0005423_abnormal_somatic_nervous | 1.91813479 |
| 20 | MP0004145_abnormal_muscle_electrophysio | 1.91811625 |
| 21 | MP0002736_abnormal_nociception_after | 1.86453056 |
| 22 | MP0001440_abnormal_grooming_behavior | 1.85644830 |
| 23 | MP0003329_amyloid_beta_deposits | 1.84190958 |
| 24 | MP0000920_abnormal_myelination | 1.78007990 |
| 25 | MP0003122_maternal_imprinting | 1.77854478 |
| 26 | MP0002909_abnormal_adrenal_gland | 1.77544554 |
| 27 | MP0001501_abnormal_sleep_pattern | 1.75196078 |
| 28 | MP0002733_abnormal_thermal_nociception | 1.74696835 |
| 29 | MP0003705_abnormal_hypodermis_morpholog | 1.73469059 |
| 30 | MP0004215_abnormal_myocardial_fiber | 1.72240185 |
| 31 | MP0001486_abnormal_startle_reflex | 1.71923698 |
| 32 | MP0000013_abnormal_adipose_tissue | 1.69437852 |
| 33 | MP0004130_abnormal_muscle_cell | 1.67369126 |
| 34 | MP0001958_emphysema | 1.62236311 |
| 35 | MP0000778_abnormal_nervous_system | 1.60341633 |
| 36 | MP0002184_abnormal_innervation | 1.60306203 |
| 37 | MP0002067_abnormal_sensory_capabilities | 1.58644117 |
| 38 | MP0001970_abnormal_pain_threshold | 1.56624783 |
| 39 | MP0004036_abnormal_muscle_relaxation | 1.54289743 |
| 40 | MP0000749_muscle_degeneration | 1.48687772 |
| 41 | MP0003279_aneurysm | 1.46768109 |
| 42 | MP0004084_abnormal_cardiac_muscle | 1.44723651 |
| 43 | MP0004924_abnormal_behavior | 1.43802825 |
| 44 | MP0005386_behavior/neurological_phenoty | 1.43802825 |
| 45 | MP0005058_abnormal_lysosome_morphology | 1.42724290 |
| 46 | MP0008569_lethality_at_weaning | 1.42025355 |
| 47 | MP0004510_myositis | 1.38748439 |
| 48 | MP0002557_abnormal_social/conspecific_i | 1.34741697 |
| 49 | MP0003646_muscle_fatigue | 1.34088711 |
| 50 | MP0001984_abnormal_olfaction | 1.32599307 |
| 51 | MP0002822_catalepsy | 1.29739153 |
| 52 | MP0004811_abnormal_neuron_physiology | 1.29086913 |
| 53 | MP0005645_abnormal_hypothalamus_physiol | 1.27727537 |
| 54 | MP0000955_abnormal_spinal_cord | 1.26866053 |
| 55 | MP0003075_altered_response_to | 1.26811229 |
| 56 | MP0000747_muscle_weakness | 1.26626956 |
| 57 | MP0004085_abnormal_heartbeat | 1.26551105 |
| 58 | MP0004484_altered_response_of | 1.26268718 |
| 59 | MP0004233_abnormal_muscle_weight | 1.25665011 |
| 60 | MP0005620_abnormal_muscle_contractility | 1.25214543 |
| 61 | MP0003172_abnormal_lysosome_physiology | 1.24565767 |
| 62 | MP0003137_abnormal_impulse_conducting | 1.24082340 |
| 63 | MP0003633_abnormal_nervous_system | 1.15483704 |
| 64 | MP0005623_abnormal_meninges_morphology | 1.15279992 |
| 65 | MP0001299_abnormal_eye_distance/ | 1.13552095 |
| 66 | MP0002066_abnormal_motor_capabilities/c | 1.11068046 |
| 67 | MP0002972_abnormal_cardiac_muscle | 1.10362575 |
| 68 | MP0005646_abnormal_pituitary_gland | 1.10249942 |
| 69 | MP0004087_abnormal_muscle_fiber | 1.09726472 |
| 70 | MP0002882_abnormal_neuron_morphology | 1.09602844 |
| 71 | MP0002295_abnormal_pulmonary_circulatio | 1.02377298 |
| 72 | MP0005330_cardiomyopathy | 1.01089729 |
| 73 | MP0001348_abnormal_lacrimal_gland | 0.99649786 |
| 74 | MP0001502_abnormal_circadian_rhythm | 0.98538199 |
| 75 | MP0000759_abnormal_skeletal_muscle | 0.98149105 |
| 76 | MP0004272_abnormal_basement_membrane | 0.94244195 |
| 77 | MP0003690_abnormal_glial_cell | 0.93095962 |
| 78 | MP0005187_abnormal_penis_morphology | 0.92174181 |
| 79 | MP0003632_abnormal_nervous_system | 0.92113562 |
| 80 | MP0002106_abnormal_muscle_physiology | 0.91340976 |
| 81 | MP0005369_muscle_phenotype | 0.89848385 |
| 82 | MP0003631_nervous_system_phenotype | 0.89709284 |
| 83 | MP0003634_abnormal_glial_cell | 0.89524121 |
| 84 | MP0004885_abnormal_endolymph | 0.89361535 |
| 85 | MP0002108_abnormal_muscle_morphology | 0.88587380 |
| 86 | MP0001529_abnormal_vocalization | 0.88084238 |
| 87 | MP0002090_abnormal_vision | 0.87831672 |
| 88 | MP0005535_abnormal_body_temperature | 0.87411891 |
| 89 | MP0008775_abnormal_heart_ventricle | 0.86776778 |
| 90 | MP0000604_amyloidosis | 0.85480685 |
| 91 | MP0002269_muscular_atrophy | 0.85469195 |
| 92 | MP0002971_abnormal_brown_adipose | 0.85163528 |
| 93 | MP0003879_abnormal_hair_cell | 0.84804039 |
| 94 | MP0006138_congestive_heart_failure | 0.84201323 |
| 95 | MP0004142_abnormal_muscle_tone | 0.83882283 |
| 96 | MP0002332_abnormal_exercise_endurance | 0.82950069 |
| 97 | MP0005503_abnormal_tendon_morphology | 0.82121408 |
| 98 | MP0000003_abnormal_adipose_tissue | 0.82006229 |
| 99 | MP0005257_abnormal_intraocular_pressure | 0.81338083 |
| 100 | MP0005167_abnormal_blood-brain_barrier | 0.81260830 |
| 101 | MP0000750_abnormal_muscle_regeneration | 0.81039000 |
| 102 | MP0002069_abnormal_eating/drinking_beha | 0.80080724 |
| 103 | MP0010386_abnormal_urinary_bladder | 0.79786502 |
| 104 | MP0001905_abnormal_dopamine_level | 0.79275333 |
| 105 | MP0002152_abnormal_brain_morphology | 0.78773283 |
| 106 | MP0008961_abnormal_basal_metabolism | 0.78046443 |
| 107 | MP0002896_abnormal_bone_mineralization | 0.77841030 |
| 108 | MP0001177_atelectasis | 0.75058946 |
| 109 | MP0003091_abnormal_cell_migration | 0.74263127 |
| 110 | MP0001544_abnormal_cardiovascular_syste | 0.73089436 |
| 111 | MP0005385_cardiovascular_system_phenoty | 0.73089436 |
| 112 | MP0005165_increased_susceptibility_to | 0.72855405 |
| 113 | MP0003123_paternal_imprinting | 0.71063285 |
| 114 | MP0003787_abnormal_imprinting | 0.70567251 |
| 115 | MP0005595_abnormal_vascular_smooth | 0.70434845 |
| 116 | MP0005375_adipose_tissue_phenotype | 0.70351092 |
| 117 | MP0000534_abnormal_ureter_morphology | 0.68828405 |
| 118 | MP0010368_abnormal_lymphatic_system | 0.68393354 |
| 119 | MP0002229_neurodegeneration | 0.68384117 |
| 120 | MP0005670_abnormal_white_adipose | 0.68033014 |
| 121 | MP0000230_abnormal_systemic_arterial | 0.67050927 |
| 122 | MP0000569_abnormal_digit_pigmentation | 0.65404121 |
| 123 | MP0003283_abnormal_digestive_organ | 0.64541152 |
| 124 | MP0008874_decreased_physiological_sensi | 0.63651328 |
| 125 | MP0008438_abnormal_cutaneous_collagen | 0.63143385 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 4.43103817 |
| 2 | Myokymia (HP:0002411) | 4.25273896 |
| 3 | Focal seizures (HP:0007359) | 3.79670963 |
| 4 | Visual hallucinations (HP:0002367) | 3.47122747 |
| 5 | Atonic seizures (HP:0010819) | 3.39996756 |
| 6 | Protrusio acetabuli (HP:0003179) | 3.23695146 |
| 7 | Exercise-induced myalgia (HP:0003738) | 3.19238764 |
| 8 | Action tremor (HP:0002345) | 3.11701065 |
| 9 | Pheochromocytoma (HP:0002666) | 3.05342436 |
| 10 | Sudden death (HP:0001699) | 3.03504324 |
| 11 | Obstructive sleep apnea (HP:0002870) | 3.00880264 |
| 12 | Abnormality of binocular vision (HP:0011514) | 3.00633277 |
| 13 | Diplopia (HP:0000651) | 3.00633277 |
| 14 | Premature rupture of membranes (HP:0001788) | 3.00410711 |
| 15 | Supranuclear gaze palsy (HP:0000605) | 2.99454495 |
| 16 | Epileptic encephalopathy (HP:0200134) | 2.95094337 |
| 17 | Termporal pattern (HP:0011008) | 2.91506449 |
| 18 | Insidious onset (HP:0003587) | 2.91506449 |
| 19 | Absence seizures (HP:0002121) | 2.90375550 |
| 20 | Generalized tonic-clonic seizures (HP:0002069) | 2.81633349 |
| 21 | Myotonia (HP:0002486) | 2.81189661 |
| 22 | Ankle clonus (HP:0011448) | 2.80450825 |
| 23 | Progressive cerebellar ataxia (HP:0002073) | 2.78665364 |
| 24 | Febrile seizures (HP:0002373) | 2.77123790 |
| 25 | Upper limb amyotrophy (HP:0009129) | 2.64037881 |
| 26 | Distal upper limb amyotrophy (HP:0007149) | 2.64037881 |
| 27 | Muscle fiber inclusion bodies (HP:0100299) | 2.58576146 |
| 28 | Tetraplegia (HP:0002445) | 2.57921332 |
| 29 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.57860404 |
| 30 | Calf muscle hypertrophy (HP:0008981) | 2.56488922 |
| 31 | Dialeptic seizures (HP:0011146) | 2.55334282 |
| 32 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.54324268 |
| 33 | Prolonged QT interval (HP:0001657) | 2.50992084 |
| 34 | Abnormality of the calf musculature (HP:0001430) | 2.49842588 |
| 35 | Abnormal eating behavior (HP:0100738) | 2.49536279 |
| 36 | Nemaline bodies (HP:0003798) | 2.48701735 |
| 37 | Hand muscle atrophy (HP:0009130) | 2.48100119 |
| 38 | Neuroendocrine neoplasm (HP:0100634) | 2.48065227 |
| 39 | Exercise-induced muscle cramps (HP:0003710) | 2.46087223 |
| 40 | Hyporeflexia of lower limbs (HP:0002600) | 2.46043356 |
| 41 | Neurofibrillary tangles (HP:0002185) | 2.45214815 |
| 42 | Anxiety (HP:0000739) | 2.42864569 |
| 43 | Cerebral inclusion bodies (HP:0100314) | 2.40428883 |
| 44 | Difficulty running (HP:0009046) | 2.37941911 |
| 45 | Depression (HP:0000716) | 2.36988462 |
| 46 | Cerebral aneurysm (HP:0004944) | 2.36380634 |
| 47 | Spinal rigidity (HP:0003306) | 2.35995043 |
| 48 | Insomnia (HP:0100785) | 2.35554390 |
| 49 | Abnormality of the corticospinal tract (HP:0002492) | 2.35498869 |
| 50 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.35165592 |
| 51 | Syncope (HP:0001279) | 2.34700619 |
| 52 | Apathy (HP:0000741) | 2.34045335 |
| 53 | Atrial fibrillation (HP:0005110) | 2.32657369 |
| 54 | Craniofacial dystonia (HP:0012179) | 2.32278889 |
| 55 | Polyphagia (HP:0002591) | 2.30993891 |
| 56 | Ventricular fibrillation (HP:0001663) | 2.29482910 |
| 57 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.29185444 |
| 58 | Primary atrial arrhythmia (HP:0001692) | 2.29133060 |
| 59 | Vertebral compression fractures (HP:0002953) | 2.27143683 |
| 60 | Increased variability in muscle fiber diameter (HP:0003557) | 2.26446896 |
| 61 | Round ear (HP:0100830) | 2.25623196 |
| 62 | Nuclear cataract (HP:0100018) | 2.25464280 |
| 63 | Urinary urgency (HP:0000012) | 2.24760210 |
| 64 | Akinesia (HP:0002304) | 2.23470022 |
| 65 | Agitation (HP:0000713) | 2.23193286 |
| 66 | Aplasia involving bones of the extremities (HP:0009825) | 2.21555365 |
| 67 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.21555365 |
| 68 | Aplasia of the phalanges of the hand (HP:0009802) | 2.21555365 |
| 69 | Increased connective tissue (HP:0009025) | 2.21439895 |
| 70 | Neuronal loss in central nervous system (HP:0002529) | 2.20275803 |
| 71 | Dysdiadochokinesis (HP:0002075) | 2.20045708 |
| 72 | Annular pancreas (HP:0001734) | 2.17878889 |
| 73 | Vascular tortuosity (HP:0004948) | 2.17573993 |
| 74 | Abnormal EKG (HP:0003115) | 2.15882687 |
| 75 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.14537217 |
| 76 | Rigidity (HP:0002063) | 2.14474059 |
| 77 | Lower limb muscle weakness (HP:0007340) | 2.14443744 |
| 78 | Dysostosis multiplex (HP:0000943) | 2.12124216 |
| 79 | Broad-based gait (HP:0002136) | 2.11559952 |
| 80 | Asymmetric septal hypertrophy (HP:0001670) | 2.11370063 |
| 81 | Supraventricular tachycardia (HP:0004755) | 2.11159401 |
| 82 | Truncal ataxia (HP:0002078) | 2.10440794 |
| 83 | Slender build (HP:0001533) | 2.10334322 |
| 84 | Diminished motivation (HP:0000745) | 2.10219874 |
| 85 | Impaired social interactions (HP:0000735) | 2.10060507 |
| 86 | Abnormal social behavior (HP:0012433) | 2.10060507 |
| 87 | EMG: myopathic abnormalities (HP:0003458) | 2.08651787 |
| 88 | Hypoventilation (HP:0002791) | 2.08418694 |
| 89 | Supraventricular arrhythmia (HP:0005115) | 2.08238261 |
| 90 | Distal lower limb amyotrophy (HP:0008944) | 2.07322649 |
| 91 | Poor eye contact (HP:0000817) | 2.06642526 |
| 92 | Torticollis (HP:0000473) | 2.04408177 |
| 93 | Oligomenorrhea (HP:0000876) | 2.03878481 |
| 94 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.03484419 |
| 95 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.03484419 |
| 96 | Abnormality of glycolipid metabolism (HP:0010969) | 2.03484419 |
| 97 | Mutism (HP:0002300) | 2.01280963 |
| 98 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.01252099 |
| 99 | Hyperventilation (HP:0002883) | 2.01047697 |
| 100 | Abnormal atrioventricular conduction (HP:0005150) | 2.00494388 |
| 101 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.00407677 |
| 102 | Mucopolysacchariduria (HP:0008155) | 2.00407677 |
| 103 | Arterial tortuosity (HP:0005116) | 1.98657287 |
| 104 | Shallow orbits (HP:0000586) | 1.98493675 |
| 105 | Excessive salivation (HP:0003781) | 1.97193556 |
| 106 | Drooling (HP:0002307) | 1.97193556 |
| 107 | Progressive inability to walk (HP:0002505) | 1.96858442 |
| 108 | Bundle branch block (HP:0011710) | 1.96057661 |
| 109 | Genetic anticipation (HP:0003743) | 1.95927367 |
| 110 | Amblyopia (HP:0000646) | 1.95876454 |
| 111 | Lower limb amyotrophy (HP:0007210) | 1.95578051 |
| 112 | Postural instability (HP:0002172) | 1.95320292 |
| 113 | Muscle fiber splitting (HP:0003555) | 1.94457691 |
| 114 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.94431928 |
| 115 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.94431928 |
| 116 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.94431928 |
| 117 | Abnormality of the lower motor neuron (HP:0002366) | 1.94200979 |
| 118 | Failure to thrive in infancy (HP:0001531) | 1.92993710 |
| 119 | Type 1 muscle fiber predominance (HP:0003803) | 1.92639965 |
| 120 | Muscle stiffness (HP:0003552) | 1.92272357 |
| 121 | Myoglobinuria (HP:0002913) | 1.92021364 |
| 122 | Heart block (HP:0012722) | 1.91164887 |
| 123 | Dysmetria (HP:0001310) | 1.90581233 |
| 124 | Broad metatarsal (HP:0001783) | 1.90566073 |
| 125 | Mitral stenosis (HP:0001718) | 1.90125724 |
| 126 | Epileptiform EEG discharges (HP:0011182) | 1.88200723 |
| 127 | Abnormality of pain sensation (HP:0010832) | 1.87907290 |
| 128 | Impaired pain sensation (HP:0007328) | 1.87907290 |
| 129 | Dysmetric saccades (HP:0000641) | 1.86460803 |
| 130 | Turricephaly (HP:0000262) | 1.86261819 |
| 131 | Scanning speech (HP:0002168) | 1.85460899 |
| 132 | Papilledema (HP:0001085) | 1.85228173 |
| 133 | Ventricular arrhythmia (HP:0004308) | 1.85109966 |
| 134 | Fetal akinesia sequence (HP:0001989) | 1.85078871 |
| 135 | Frequent falls (HP:0002359) | 1.84915603 |
| 136 | Rapidly progressive (HP:0003678) | 1.83971309 |
| 137 | Foot dorsiflexor weakness (HP:0009027) | 1.83619834 |
| 138 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.83499768 |
| 139 | Distal lower limb muscle weakness (HP:0009053) | 1.83387373 |
| 140 | Spastic gait (HP:0002064) | 1.83296105 |
| 141 | Bradykinesia (HP:0002067) | 1.83175502 |
| 142 | Wormian bones (HP:0002645) | 1.83093240 |
| 143 | Bladder diverticulum (HP:0000015) | 1.82752599 |
| 144 | Bradycardia (HP:0001662) | 1.82234121 |
| 145 | Abnormality of dentin (HP:0010299) | 1.80901599 |
| 146 | Megalencephaly (HP:0001355) | 1.80378510 |
| 147 | Ketoacidosis (HP:0001993) | 1.78878142 |
| 148 | Hypercortisolism (HP:0001578) | 1.78274969 |
| 149 | Hyperthyroidism (HP:0000836) | 1.77220203 |
| 150 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.74373163 |
| 151 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.74373163 |
| 152 | Buphthalmos (HP:0000557) | 1.72655042 |
| 153 | Hemiparesis (HP:0001269) | 1.72275458 |
| 154 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.71908561 |
| 155 | Intention tremor (HP:0002080) | 1.69519138 |
| 156 | Focal dystonia (HP:0004373) | 1.69117029 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 3.34831912 |
| 2 | MARK1 | 3.26756553 |
| 3 | MAP3K4 | 2.73944565 |
| 4 | MAP3K9 | 2.73001105 |
| 5 | PHKG2 | 2.72339810 |
| 6 | PHKG1 | 2.72339810 |
| 7 | MINK1 | 2.50967789 |
| 8 | MAP2K4 | 2.23701789 |
| 9 | EPHA4 | 2.09394766 |
| 10 | MAP2K7 | 2.05162191 |
| 11 | LMTK2 | 2.04940009 |
| 12 | NTRK1 | 2.00940125 |
| 13 | PAK6 | 1.87760935 |
| 14 | NTRK2 | 1.69761457 |
| 15 | DAPK2 | 1.64885220 |
| 16 | MAP3K12 | 1.63351230 |
| 17 | KSR2 | 1.59425701 |
| 18 | LATS2 | 1.58205397 |
| 19 | TESK1 | 1.53548836 |
| 20 | CASK | 1.51340265 |
| 21 | PAK3 | 1.41955308 |
| 22 | MAPK13 | 1.33796697 |
| 23 | CAMKK1 | 1.30334594 |
| 24 | FER | 1.29409073 |
| 25 | TTN | 1.27999620 |
| 26 | TRIB3 | 1.26306255 |
| 27 | PRKD3 | 1.23702666 |
| 28 | CDK5 | 1.21954922 |
| 29 | RET | 1.19610496 |
| 30 | KSR1 | 1.14270297 |
| 31 | PLK2 | 1.14019291 |
| 32 | ICK | 1.11265178 |
| 33 | MOS | 1.11192053 |
| 34 | GRK5 | 1.09830413 |
| 35 | MAP3K13 | 1.09239357 |
| 36 | CAMK1G | 1.07294742 |
| 37 | STK38 | 1.04352417 |
| 38 | SGK494 | 1.03280639 |
| 39 | SGK223 | 1.03280639 |
| 40 | MAP3K2 | 1.03089108 |
| 41 | ERBB3 | 1.03060813 |
| 42 | OBSCN | 0.99377897 |
| 43 | CAMK2A | 0.97268633 |
| 44 | PRKCG | 0.92968926 |
| 45 | WNK3 | 0.91820518 |
| 46 | PTK2 | 0.90416317 |
| 47 | UHMK1 | 0.88558898 |
| 48 | CAMKK2 | 0.87481488 |
| 49 | RIPK1 | 0.87235810 |
| 50 | PKN2 | 0.86831353 |
| 51 | PIK3CA | 0.85532971 |
| 52 | PDK4 | 0.85490194 |
| 53 | PDK3 | 0.85490194 |
| 54 | ARAF | 0.85405639 |
| 55 | PRKCH | 0.83247958 |
| 56 | PINK1 | 0.83222328 |
| 57 | PDGFRA | 0.81003912 |
| 58 | INSRR | 0.80420474 |
| 59 | GRK7 | 0.78705179 |
| 60 | MAP2K1 | 0.78637426 |
| 61 | EPHB2 | 0.78250819 |
| 62 | SGK3 | 0.77231912 |
| 63 | SGK2 | 0.76770678 |
| 64 | DDR2 | 0.75567304 |
| 65 | RIPK4 | 0.74743800 |
| 66 | MAP3K11 | 0.74586069 |
| 67 | PTK2B | 0.74291335 |
| 68 | PKN1 | 0.73900787 |
| 69 | MYLK | 0.73820923 |
| 70 | WNK1 | 0.72623107 |
| 71 | ERN1 | 0.70624637 |
| 72 | SIK2 | 0.70471956 |
| 73 | ROCK1 | 0.70422426 |
| 74 | MAPK12 | 0.70240790 |
| 75 | NEK1 | 0.70223053 |
| 76 | PRKCE | 0.69599183 |
| 77 | RPS6KA2 | 0.69576183 |
| 78 | DAPK3 | 0.69256795 |
| 79 | CAMK2D | 0.69053586 |
| 80 | WNK4 | 0.68754348 |
| 81 | CDK14 | 0.68626019 |
| 82 | CSNK1G2 | 0.67712070 |
| 83 | PRPF4B | 0.67703639 |
| 84 | EPHB1 | 0.65729767 |
| 85 | PDK1 | 0.65303923 |
| 86 | TYRO3 | 0.63301804 |
| 87 | CAMK1D | 0.62726959 |
| 88 | TAOK2 | 0.62337670 |
| 89 | STK39 | 0.61900568 |
| 90 | FGFR2 | 0.61846777 |
| 91 | LIMK1 | 0.61549337 |
| 92 | CDK18 | 0.61364843 |
| 93 | CAMK1 | 0.61187217 |
| 94 | ROCK2 | 0.60890966 |
| 95 | PDPK1 | 0.60643992 |
| 96 | CDK15 | 0.60415599 |
| 97 | CAMK2G | 0.60292295 |
| 98 | PNCK | 0.59781345 |
| 99 | MAP3K1 | 0.59090726 |
| 100 | MAP3K7 | 0.58759779 |
| 101 | CAMK2B | 0.58307030 |
| 102 | PRKCZ | 0.57541066 |
| 103 | DMPK | 0.57456323 |
| 104 | PRKD2 | 0.56419304 |
| 105 | OXSR1 | 0.55698361 |
| 106 | PDK2 | 0.54745372 |
| 107 | SIK1 | 0.54677082 |
| 108 | CAMK4 | 0.54405388 |
| 109 | SGK1 | 0.54083200 |
| 110 | STK11 | 0.52643476 |
| 111 | TNIK | 0.52458233 |
| 112 | ADRBK1 | 0.52232599 |
| 113 | MARK2 | 0.51681856 |
| 114 | MAPK10 | 0.51271650 |
| 115 | PAK2 | 0.51107044 |
| 116 | CDC42BPA | 0.51021400 |
| 117 | DYRK1A | 0.50874337 |
| 118 | BRAF | 0.49883205 |
| 119 | DAPK1 | 0.49018916 |
| 120 | CDK11A | 0.47543675 |
| 121 | PRKG2 | 0.43078063 |
| 122 | MAP2K6 | 0.42548889 |
| 123 | RPS6KA3 | 0.41839175 |
| 124 | PRKD1 | 0.41715479 |
| 125 | ABL2 | 0.41613720 |
| 126 | PRKAA1 | 0.37187763 |
| 127 | MAPK7 | 0.36839728 |
| 128 | BRSK1 | 0.35711696 |
| 129 | ALK | 0.35470276 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.60912816 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.40608275 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.13593189 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 1.97970015 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.93464654 |
| 6 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.91179426 |
| 7 | Olfactory transduction_Homo sapiens_hsa04740 | 1.84040456 |
| 8 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.74403429 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 1.72097606 |
| 10 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.66255883 |
| 11 | Long-term potentiation_Homo sapiens_hsa04720 | 1.66194967 |
| 12 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.65161926 |
| 13 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.63522119 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.62974235 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.59538222 |
| 16 | Salivary secretion_Homo sapiens_hsa04970 | 1.59340110 |
| 17 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.56810109 |
| 18 | Renin secretion_Homo sapiens_hsa04924 | 1.56273645 |
| 19 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.54187229 |
| 20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.51056761 |
| 21 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.49934794 |
| 22 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.49527667 |
| 23 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.46476161 |
| 24 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.44918735 |
| 25 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.40118305 |
| 26 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.39043859 |
| 27 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.38311017 |
| 28 | Taste transduction_Homo sapiens_hsa04742 | 1.34795463 |
| 29 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.29312786 |
| 30 | Cocaine addiction_Homo sapiens_hsa05030 | 1.26215397 |
| 31 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.21532503 |
| 32 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.20475638 |
| 33 | Gap junction_Homo sapiens_hsa04540 | 1.16953263 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.16823421 |
| 35 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.16389341 |
| 36 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.15833225 |
| 37 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.15104494 |
| 38 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.14873241 |
| 39 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.14456475 |
| 40 | Long-term depression_Homo sapiens_hsa04730 | 1.13975801 |
| 41 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.12821153 |
| 42 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.11844347 |
| 43 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.10434527 |
| 44 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.10131927 |
| 45 | Axon guidance_Homo sapiens_hsa04360 | 1.08545505 |
| 46 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.07576389 |
| 47 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.06927109 |
| 48 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.00599112 |
| 49 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.00143099 |
| 50 | Other glycan degradation_Homo sapiens_hsa00511 | 0.99211076 |
| 51 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.98184107 |
| 52 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.97649136 |
| 53 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.94248898 |
| 54 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.93657734 |
| 55 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.91237881 |
| 56 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.90955875 |
| 57 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.90609006 |
| 58 | Melanogenesis_Homo sapiens_hsa04916 | 0.87573274 |
| 59 | Bile secretion_Homo sapiens_hsa04976 | 0.86378921 |
| 60 | Glioma_Homo sapiens_hsa05214 | 0.85698919 |
| 61 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.84646601 |
| 62 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.84636240 |
| 63 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.82590527 |
| 64 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.82590289 |
| 65 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.81606629 |
| 66 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.78474061 |
| 67 | Alzheimers disease_Homo sapiens_hsa05010 | 0.77323778 |
| 68 | Lysosome_Homo sapiens_hsa04142 | 0.77129903 |
| 69 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.73457704 |
| 70 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.71609822 |
| 71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.70696453 |
| 72 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.70081384 |
| 73 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.68287661 |
| 74 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.67656692 |
| 75 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.67313004 |
| 76 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.66459336 |
| 77 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.65841323 |
| 78 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.64642877 |
| 79 | Parkinsons disease_Homo sapiens_hsa05012 | 0.62913008 |
| 80 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.61937920 |
| 81 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.60327010 |
| 82 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.59458434 |
| 83 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.59301419 |
| 84 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.58997844 |
| 85 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58892928 |
| 86 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.58500235 |
| 87 | Endocytosis_Homo sapiens_hsa04144 | 0.58401103 |
| 88 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.57919997 |
| 89 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.57568036 |
| 90 | Prion diseases_Homo sapiens_hsa05020 | 0.55791505 |
| 91 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.55469707 |
| 92 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.55187844 |
| 93 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.54923104 |
| 94 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.54365244 |
| 95 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.52806997 |
| 96 | Endometrial cancer_Homo sapiens_hsa05213 | 0.52064255 |
| 97 | Amoebiasis_Homo sapiens_hsa05146 | 0.52018246 |
| 98 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.51656858 |
| 99 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.51038229 |
| 100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.49951581 |
| 101 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49434501 |
| 102 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49232350 |
| 103 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47304667 |
| 104 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.47218448 |
| 105 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.46314815 |
| 106 | Insulin resistance_Homo sapiens_hsa04931 | 0.45913879 |
| 107 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.45101357 |
| 108 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.43927822 |
| 109 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.43742339 |
| 110 | Tight junction_Homo sapiens_hsa04530 | 0.43532352 |
| 111 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.42967181 |
| 112 | Circadian rhythm_Homo sapiens_hsa04710 | 0.42843753 |
| 113 | Focal adhesion_Homo sapiens_hsa04510 | 0.42654418 |
| 114 | Histidine metabolism_Homo sapiens_hsa00340 | 0.41149217 |
| 115 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.40123346 |
| 116 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.39974791 |
| 117 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.39675765 |
| 118 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.39568902 |
| 119 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.39147119 |
| 120 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.39113866 |
| 121 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.38569356 |
| 122 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.38508049 |
| 123 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.38186861 |
| 124 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.38098270 |

